Iodine Avid Papillary Thyroid Cancer Showing
                    PSMA-Expression in 68Ga-PSMA Ligand PET/CT

Nuklearmedizin 2019; 58(01): 50-51
DOI: 10.1055/a-0808-0832

Case Report

Iodine Avid Papillary Thyroid Cancer Showing PSMA-Expression in ⁶⁸Ga-PSMA Ligand PET/CT

Christina Nguyen Ngoc

¹Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Klinik für Nuklearmedizin
Christian Happel

¹Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Klinik für Nuklearmedizin
Amir Sabet

¹Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Klinik für Nuklearmedizin
Wolf Otto Bechstein

²Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Zentrum der Chirurgie
Frank Grünwald

¹Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Klinik für Nuklearmedizin

Literature
1 Damle NA, Bal C, Singh TP. et al. Anaplastic thyroid carcinoma on 68 Ga-PSMA PET/CT: Opening new frontiers. Eur J Nucl Med Mol Imaging. 2018
2 Lütje S, Gomez B, Cohnen J. et al. Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT. Clin Nucl Med 2017; 42 (01) 20-5 doi: 10.1097/RLU.0000000000001454
3 Moore M, Panjwani S, Mathew R. et al. Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target. Endocr Pathol 2017; 28 (04) 339-44 doi: 10.1007/s12022–017–9500–9
4 Reubi JC, Krenning E, Lamberts SW. et al. Somatostatin receptors in malignant tissues. In: The Journal of steroid biochemistry and molecular biology 1990; 37 (06) 1073-1077
5 Verburg FA, Krohn T, Heinzel A. et al. First evidence of PSMA expression in differentiated thyroid cancer using ⁶⁸GaPSMA-HBED-CC PET/CT. Eur J Nucl Med Mol Imaging 2015; 42 (10) 1622-1623 doi: 10.1007/s00259–015–3065-y